Once a salivary gland tumor is identified as ETV6-NTRK3 positive, the tumor can be classified as SCSG (rather than mucoepidermoid carcinoma, AciCC, or polymorphous adenocarcinoma), and then treatment with TRK inhibitors can be initiated. Here, NTRK3 is linked to mucoepidermoid carcinoma.